通过FDA批准的RdRp抑制剂抑制HEV复制

Preeti Hooda1, Mohammed Al-Dosari2, Neha Sinha3

  • 1Virology Lab, Department of Life Sciences, Shiv Nadar Institute of Eminence, Gautam Budh Nagar 201314, India.

ACS omega
|November 16, 2023
PubMed
概括

费维皮拉维尔和索福斯布维尔在治疗E型肝炎病毒 (HEV) 感染方面表现有前途,通过抑制病毒RNA依赖RNA聚合酶. 组合疗法显著减少了病毒RNA,这表明法维皮拉维尔是一种潜在的抗HEV药物.